California · Nonprofit
THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER
THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER (California) receives grants from 22 organizations whose IRS filings report $2,082,963 to it, the largest being NATIONAL PHILANTHROPIC TRUST ($430,500). 11 of them have funded it in more than one year, and 79% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $11M
- Funders on record
- 22
- Grants received
- $2.1M
- Net assets
- $1.5M
What The Translational Pulmonary and Immunology Research Center does
Mission
Tpirc is a non-profit clinical care and research center that focuses on the development of cutting-edge, individualized treatment protocols for rare and orphan diseases utilizing comprehensive diagnostic tools and patient driven research. Our mission is two-fold to advance treatment discovery at a pace which helps our patients today, while building a scalable model of success to accelerate the rate of research discovery for all diseases.
As stated on its FY2024 Form 990.
Program
The center operates a rare disease-specific institute that combines basic/transational research, cutting-edge clinical care and advocacy (disease education and awareness, and fundraising) under one physical structure in long beach, california. The center focuses on five medical conditions: adult cystic fibrosis, food allergy and intolerance, bronchiectasis, immune deficiency, and airway inflammatory disorders.
$8,995,085 spent$10,422,479 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $8,995,085.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $6.2M to $11M (+76%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 6% · 2021 0% · 2022 2%. Grants only. Government contracts and fees sit inside program revenue.
8% of THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER’s revenue is contributions — more donation-reliant than the typical peer (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Dr Inderpal Randhawa
CEO and founder
Board chair
Paul Orlin
Board chair
As listed on its FY2024 Form 990.
The chief executive listed changed between the FY2021 and FY2022 filings.
Who funds it, year by year
2017 → 2023: the base broadened from 4 funders to 10 funders, grant income rose $144k → $353k.
18 of 22 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 79% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER has a broad base — no single funder exceeds 21% of grant income, and it takes 3 funders to reach half.
the vertical line marks half of all grant income — 3 funders to its left
79% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER.
Largest funder’s share by year: 2017 69% · 2018 66% · 2019 53% · 2020 31% · 2021 44% · 2022 45% · 2023 42% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
38% of THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER's funders are still giving 3 years after their first grant; 50% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
79% of THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $437k that is directly attributable, 72% of it comes from California funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $1.6M arriving through sponsors registered in 12 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER has grown faster than three-quarters of the 4,580 health nonprofits its size.
this organization peer median middle 50% of peers· 4,580 health nonprofits $10M–$100M, FY2024
Organizations like THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
68% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 1 state
Part of a family of 1 related entity
- Foundation Labs · disregarded
Screen this organization
A dated, signed PDF of the compliance screen for THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER?
- THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER (California) receives grants from 22 organizations whose IRS filings report $2,082,963 to it, the largest being NATIONAL PHILANTHROPIC TRUST ($430,500). 11 of them have funded it in more than one year, and 79% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER have?
- IRS filings report 22 organizations giving $2,082,963 in grants to THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER, 11 of which have funded it in more than one year.
- Who is the largest funder of THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER?
- NATIONAL PHILANTHROPIC TRUST is the largest funder on record, with $430,500 in grants. The full list of funders is on this page.
- How can an organization like THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 22 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing